Figure 1.
Figure 1. Proteinase inhibitor 9 (PI-9) and bcl-2 expression in lymphoma cells. Proteinase inhibitor 9 (PI-9) expression (A) and bcl-2 expression (B) were determined by flow cytometry. HLA-A2–positive lymphoma cells (▪) were used later for CTL experiments. HLA-A2–negative cells are indicated with □. Background fluorescence intensity was subtracted. Means and standard error of the mean (SEM) of 3 experiments are shown for cell lines (Ai and Bi). One out of 2 experiments is shown for primary lymphoma cells (Aii and Bii). Concordant results were obtained in both experiments. MFI indicates mean fluorescent intensity.

Proteinase inhibitor 9 (PI-9) and bcl-2 expression in lymphoma cells. Proteinase inhibitor 9 (PI-9) expression (A) and bcl-2 expression (B) were determined by flow cytometry. HLA-A2–positive lymphoma cells (▪) were used later for CTL experiments. HLA-A2–negative cells are indicated with □. Background fluorescence intensity was subtracted. Means and standard error of the mean (SEM) of 3 experiments are shown for cell lines (Ai and Bi). One out of 2 experiments is shown for primary lymphoma cells (Aii and Bii). Concordant results were obtained in both experiments. MFI indicates mean fluorescent intensity.

Close Modal

or Create an Account

Close Modal
Close Modal